One of the most common disorders seen in pregnancy today falls into the realm of “hypertensive disorders of pregnancy” occurring in 12-22% of pregnancies. Understanding the classification and management of this population of patients will allow for better care and improved outcomes. Not only do these disorders account for 17% of maternal mortality in the United States but also account for one of the leading causes of premature birth which increases neonatal morbidity and mortality. National and International organizations have developed guidelines for the management of hypertensive disorders in pregnancy to reduce maternal mortality. These organizations include the American Congress of Obstetrics and Gynecologists (ACOG), National Institute for Health and Clinical Excellence (NICE), and Society for Obstetricians and Gynaecologists of Canada (SOGC). This presentation will review some of the guidelines developed and the importance of an interdisciplinary approach to the management of patients with hypertensive disorders of pregnancy.
Learning Objectives:
Objective 1: To understand the classification of hypertensive disorders in pregnancy and the postpartum period.
Objective 2: To review the recommendations for the ante, intra, and postpartum nursing management and assessment of preeclampsia.
Objective 3: To review the recommendations for use of antihypertensive agents in preeclampsia and the use of magnesium sulfate in the management of patients with preeclampsia.
To Continue, Please Select Your Country of Residence
Whoops! Please select your Country before clicking "Submit"
The GOLD Learning Lecture Library is a unique & convenient resource for Healthcare Professionals, Researchers, Students and other Educators looking to stay up to date on the latest evidence-based skills and practices. Country Category pricing has been determined by World Bank Economic Indicators. Proof of residency may be requested. Learn more about our Category Pricing Here.
